Intermolecular Inc. ( IMI ) and First Solar Inc. ( FSLR ) have entered into a two-year collaboration and licensing agreement focused on further increases to the conversion efficiency of FSLR's cadmium telluride (CdTe) solar cell technology. FSLR and IMI researchers will collaborate to develop disruptive new approaches to increasing the performance of CdTe solar cell technology using IMI's proprietary High Productivity Combinatorial (HPC) platform. The program targets substantial gains in FSLR's module conversion efficiency beyond its previously announced roadmap.
IMI is down 3.1% at $8.51, trading in a 52-week range of $5.01 - $9.55. Shares have fallen 3% in the last 12 months.
FSLR is down 5.7% at $31.68, trading in a 52-week range of $11.43 - $50.20. Shares have fallen 10% in the last 12 months.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
